当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析

同和药业

(300636)

  

流通市值:32.43亿  总市值:37.52亿
流通股本:3.64亿   总股本:4.22亿

同和药业(300636)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.96亿元,每股收益0.23元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益230936.55万元,未分配利润57490.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产329508.48万元,负债98571.94万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入569,933,408.38382,051,594.68206,454,983.02722,138,705.43
营业总成本455,177,777.45295,168,592.6150,662,133.88599,899,694.96
营业利润106,011,166.6977,207,966.3149,031,953.9112,232,257.94
利润总额105,498,257.3377,141,216.3148,965,203.9112,500,347.84
净利润95,736,461.669,552,022.443,562,751.14105,983,257.15
其他综合收益----
综合收益总额95,736,461.669,552,022.443,562,751.14105,983,257.15
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计995,438,366.731,261,158,032.681,284,774,481.81,196,983,710.51
非流动资产合计2,299,646,480.152,068,875,842.522,106,094,358.022,024,456,028.48
资产总计3,295,084,846.883,330,033,875.23,390,868,839.823,221,439,738.99
流动负债合计536,381,037.93599,094,892.04672,142,270.93701,711,148.17
非流动负债合计449,338,342.76448,975,164.79447,279,507.25293,279,466.55
负债合计985,719,380.691,048,070,056.831,119,421,778.18994,990,614.72
归属于母公司股东权益合计2,309,365,466.192,281,963,818.372,271,447,061.642,226,449,124.27
股东权益合计2,309,365,466.192,281,963,818.372,271,447,061.642,226,449,124.27
负债和股东权益合计3,295,084,846.883,330,033,875.23,390,868,839.823,221,439,738.99
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计521,186,224.17359,006,670.49156,938,328.08810,706,854.65
经营活动现金流出小计359,022,399.92274,010,480.25127,194,738.95646,958,320.9
经营活动产生的现金流量净额162,163,824.2584,996,190.2429,743,589.13163,748,533.75
投资活动现金流入小计60,297,42759,590,788.1848,653,507.48162,411,077.54
投资活动现金流出小计521,271,504.37268,019,038197,329,756.62868,616,952.96
投资活动产生的现金流量净额-460,974,077.37-208,428,249.82-148,676,249.14-706,205,875.42
筹资活动现金流入小计658,487,338.8569,135,184304,950,0001,761,318,211.22
筹资活动现金流出小计740,894,705.77536,994,727.75154,753,166.8806,059,009.75
筹资活动产生的现金流量净额-82,407,366.9732,140,456.25150,196,833.2955,259,201.47
汇率变动对现金及现金等价物的影响4,760,520.454,075,239.221,553,427.991,822,579.37
现金及现金等价物净增加额-376,457,099.64-87,216,364.1132,817,601.18414,624,439.17
期末现金及现金等价物余额116,345,276.1405,586,011.63525,619,976.92492,802,375.74
最新报告期:2024-11-06
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华创证券郑辰,王宏雨0.320.410.542024-11-06
华西证券崔文亮0.300.420.542024-10-28
招商证券许菲菲0.300.390.502024-10-27
中泰证券祝嘉琦0.310.410.542024-10-26
太平洋周豫,乔露阳0.330.520.682024-10-24
TOP↑